by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersAmie Health, Inc. dba Amie

All Warning Letters

Amie Health, Inc. dba Amie

Warning LetterOpen

Amie Health, Inc. dba Amie, 382 NE 191st St., Suite 35622 Miami , FL 33179 United StatesIssued Jun 8, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations1

Issue DateJun 8, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Amie Health, Inc. dba Amie
Location: Amie Health, Inc. dba Amie, 382 NE 191st St., Suite 35622 Miami , FL 33179 United States
FEI Number: N/A
Country: United States
Issue Date: June 08, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

False & Misleading Claims/Misbranded (Telehealth)

Amie Health, Inc. dba Amie FDA Warning Letter, June 8, 2026